SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

iSERA Lifesciences touches roof on getting nod to acquire 100% stake in iSERA Biological

22 Apr 2026 Evaluate

iSERA Lifesciences is currently trading at upper limit of Rs. 72.71, up by 1.42 points or 1.99% from its previous closing of Rs. 71.29 on the BSE.

The scrip opened at Rs. 72.71 and has touched a high and low of Rs. 72.71 and Rs. 72.71 respectively. So far 25 shares were traded on the counter.

The BSE group 'XT' stock of face value Rs. 10 has touched a 52 week high of Rs. 72.71 on 22-Apr-2026 and a 52 week low of Rs. 1.50 on 03-Jul-2025.

Last one week high and low of the scrip stood at Rs. 72.71 and Rs. 67.19 respectively. The current market cap of the company is Rs. 61.14 crore.

The promoters holding in the company stood at 58.63%, while Non-Institutions held 41.37% stake in the company.

iSERA Lifesciences has received approval from Board of Directors for acquisition of equity shares representing up to 100% of the paid-up equity share capital of iSERA Biological, an unlisted public company, comprising up to 1,61,82,800 equity shares of face value Rs 10 each, from the existing shareholders of iSERA Biological, for a total consideration of Rs 78,00,10,960. Upon completion of the said acquisition, iSERA Biological shall become a wholly owned subsidiary of iSERA Lifesciences.

iSERA Lifesciences (Formerly known as Covidh Technologies) is a technology services provider with an established footprint across diverse domains.

iSERA Lifesciences Share Price

77.49 0.00 (0.00%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
TCS 2394.85
Infosys 1179.20
HCL Tech. 1198.60
Wipro 197.95
Tech Mahindra 1463.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×